What is the clinical value of mHealth for patients?

Rowland SP, Fitzgerald JE, Holme T, Powell J, McGregor A. · 2020

Read What is the clinical value of mHealth for patients? by Rowland SP, Fitzgerald JE, Holme T, Powell J, McGregor A. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6957674.txt.

Introduction

Rowland and co-authors ask what health apps on phones actually do for patients. Their review appeared in NPJ Digital Medicine. Interest from patients and clinicians is high, and phone ownership is vast. Yet doctors have little guidance on which apps add real value to care.

The authors group apps by function: prevention and behaviour change, self-management of a condition, and diagnosis among them. Evidence from systematic reviews supports benefit in only a small number of clinical scenarios. They explain what regulator clearance does and does not promise. Data security and privacy worry patients deeply. Patients also rarely help design the guidelines, so professional views may not match theirs. Independent review sites, they suggest, could help steer choices.

Catalog record

CREATORRowland SP, Fitzgerald JE, Holme T, Powell J, McGregor A.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6957674

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

What is the clinical value of mHealth for patients? By Simon P Rowland, J Edward Fitzgerald, Thomas Holme, John Powell, Alison McGregor Published in: NPJ Digital Medicine DOI: 10.1038/s41746-019-0206-x ABSTRACT Abstract Despite growing interest from both patients and healthcare providers, there is little clinical guidance on how mobile apps should be utilized to add value to patient care. We categorize apps according to their functionality (e.g. preventative behavior change, digital self-management of a specific condition, diagnostic) and discuss evidence for effectiveness from published systematic reviews and meta-analyses and the relevance to patient care. We discuss the limitations of the current literature describing clinical outcomes from mHealth apps, what FDA clearance means now (510(k)/de novo FDA clearance) and in the future. We discuss data security and privacy as a major concern for patients when using mHealth apps. Patients are often not involved in the development of mobile health guidelines, and professionals’ views regarding high-quality health apps may not reflect patients’ views. We discuss efforts to develop guidelines for the development of safe and effective mHealth apps in the US and elsewhere and the role of independent app reviews sites in identifying mHealth apps for patient care. There are only a small number of clinical scenarios where published evidence suggests that mHealth apps may improve patient outcomes. Subject terms: Public health, Therapeutics INTRODUCTION The World Health Organization (WHO) Global Observatory for eHealth (GOe) defines mHealth as medical and public health practice supported by mobile devices.1 In total, 2.5 billion people worldwide own a mobile phone and there is huge potential for mHealth to facilitate unprecedented access to specialist clinical diagnostics and treatment advice. In the US 56% of physicians have discussed mHealth with patients and 26% have been asked about mHealth by a patient (PWC Provider Survey). Despite growing interest from both patients and healthcare providers, there is little clinical guidance on how mHealth apps should be utilized to add value to patient care, where value might include improvements in speed and accuracy of diagnosis, personalized treatment regimes, behavioral change advice, patient education or improved access to established therapies such as cognitive behavioral therapy (CBT). This article discusses the potential value of mHealth apps for patients and the challenges that clinicians face in discussing mHealth apps in clinic. Specifically, the following questions are addressed: (1) What are the different app functionalities that have clinical evidence of value added to patient care? (2) What are the challenges in taking an evidence-based approach to clinical use of mHealth apps? (3) How can medical professional societies and clinicians support patients in obtaining value from mHealth apps? (4) What value will mHealth hold for patients in the future? THE SCOPE OF MHEALTH FUNCTIONALITIES THAT HAVE SHOWN CLINICAL EVIDENCE FOR PATIENT CARE One approach to categorization of mHealth apps which is used in the UK by the National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) is by their functionality.2 This functional classification is a basis for comparisons of levels of evidence for apps in clinical medicine. The functional categories of mHealth apps most relevant to use in clinical practice are addressed within this article and include the following: - support clinical diagnosis and/or decision making; - improve clinical outcomes from established treatment pathways through behavior change and enhancement of patient adherence and compliance with treatment; - act as standalone digital therapeutics; and - primarily to deliver disease related education. In this section we consider the value to patients of mHealth apps in each of these categories. Other categories of mHealth apps with functionalities such as care coordination, health information portals, and those designed for rehabilitation are not included in this review. Diagnostics and clinical decision making through mHealth apps It is estimated that more than 50 million people worldwide use app-based self-triage and3 a recent systematic review demonstrated that interactive symptom checkers are the most frequently investigated category of diagnostic app.3 An audit of 23 prominent symptom checker apps in a US clinic found that appropriate triage advice was given in 80% of emergency cases, which is comparable to that seen from junior doctors and senior nurses.4 However diagnostic accuracy was only 34% and triage advice was considered appropriate in only 55% of non-emergent cases. Diagnostic symptom checker apps targeted at specific symptoms such as hand or knee pain have been shown to frequently deliver inaccurate advice.3 Published evidence suggests that symptom checker apps are often risk averse and may lead to unnecessary consultations in the non-emergency setting.3 The other major category of diagnostic apps use algorithms to screen either photographs or data from smartphone embedded sensors. A 2017 systematic review identified 30 manuscripts investigating 35 apps most commonly intended to screen photographs for melanoma or diagnose tremor through analyses of movements.5 A pooled estimate of diagnostic sensitivity for such apps was reported as 82% (95% CI 0.56–0.94) and pooled specificity as 89% (95% CI 0.70–0.97).4 However, experts have highlighted that current evidence is not at a level to suggest that apps screening photographs could replace a clinical consultation.6 Despite the current limitations of diagnostic mHealth apps there is huge potential and evidence is starting to emerge to demonstrate clinically significant improvements in morbidity and mortality outcomes in specific scenarios. For example, an app designed to screen patient reported outcomes for signs of disease recurrence to allow for early re-intervention in previously treated lung cancer patients improved median survival compared to optimized standard imaging follow-up (23 months in the experimental arm vs 14.8 months in the control arm (HR 0.62, 95% CI 0.39–0.995, P = 0.048)).7 The World Health Organization already advises that digital diagnostic platforms may be valuable for patients in low- and middle-income countries where expert clinical advice is difficult to access.8 Behavior change interventions through mHealth apps Apps are potentially powerful platforms for delivery of behavior change interventions because they can improve engagement with established strategies for prevention and treatment of disease through personalized goal setting, individualized dosing reminders, and gamification.9 Apps that are linked to wearable devices that monitor heart rate and activity level often utilize additional behavior change techniques such as social comparison and competition, self-monitoring and review of physiological changes, and other techniques centered on social cognitive theory. A systematic review and meta-analysis of published studies investigating the effect of mobile apps to improve weight loss and physical activity outcomes demonstrated reductions in BMI of 0.43 kg/m2 (95% CI −0.74 to −0.13) with much greater weight loss seen when the devices were used optimally.10 Benefits have also been seen with the use of behavior change apps to drive improvements in glycemic control in people with diabetes through improved adherence to treatment protocols.11 However the challenge is to achieve sustained improvements in clinical parameters and the long-term outcomes with use of these devices is unknown. App-based behavior change interventions are also available to address long-term non-adherence with prescribed pharmacological treatments for chronic illnesses, which is estimated to be as high as 50%.12 Common reasons for non-adherence that can be addressed through an app include forgetfulness, lack of understanding of side effects, and perceptions of lack of efficacy.13 A recent review identified 704 apps on the app store utilizing behavioral strategies to enhance medication adherence through alerts,

Read the complete text